GlaxoSmithKline Sued in Death of Man
Larry Alan Stanford died on May 21, the same day that the report implicating Avandia for increasing heart attack risk in those who took it was published. Stanford's family is suing Glaxo, alleging that the company knew the risks of the drug, yet continued to sell it anyway.
A New York law firm already has filed a class action shareholder lawsuit against Glaxo. Glaxo maintains that Avandia is a safe treatment for diabetes and that the New England Journal study was flawed.
Related Links:
Legal View: Avandia
Glaxo Failed to Warn of Diabetes Drug Risk- Lawsuit
Avandia Maker Sued Over Heart Attack
An Avandia Lawsuit Emerges, Inevitably